Coactivator stokes continuing fire of endometriosis

June 4, 2012

(Medical Xpress) -- Endometriosis, which can cause severe pain and even infertility in the estimated 8.5 million U.S. women it affects, is driven by one of the cell's master regulators ­ steroid receptor coactivator 1 or SRC-1, said researchers at Baylor College of Medicine in a report that appears online today in the journal Nature Medicine.

"This finding could lead to new therapies for this age-old condition," said Dr. Bert O'Malley, chair of molecular and cellular biology at BCM and the report's corresponding author.

The causes of are unclear, because the molecular pathways involved have not been elucidated previously. The disorder involves the abnormal growth of cells similar to those of the lining of the uterus (the endometrium) outside that organ ­ on the ovaries, fallopian tubes, pelvic cavity lining or other structures.

No one knows for sure how the endometrial tissue travels from the uterus to other structures but most believe that the tissue could back up into the abdomen through the fallopian tubes during a woman's monthly period. Estrogen can promote the growth of endometriosis.

Immortalized cells

Although the cells of endometriosis are not cancerous, they can become "immortalized," growing and reproducing and invading normal tissues. In studies in mice and human tissue, O'Malley and his colleagues identified a truncated form of SRC-1 in endometrial cells.

This coactivator fragment cooperates with two other proteins known to play a role in endometriosis ­ TNF-alpha (tumor necrosis factor alpha) and MMP9 (matrix metallopeptidase 9) ­ to keep the endometrial cells alive and growing.

"Although the full SRC-1 molecule will actually increase the death of endometriosis cells, the full coactivator gets processed by the inflammatory process into a smaller piece (an isoform) that stops the from dying," said O'Malley. "We now know the mechanism that causes this to happen."

SRC-1 isoform

Understanding the role of the isoform of SRC-1 in maintaining the endometriosis is an important step toward developing new ways to treat it, said O'Malley.

Others who took part in this work include a lead coauthor, Dr. Sang Jun Han, and Drs. Shannon M. Hawkins, Khurshida Begum, Sung Yun Jung, Ertug Kovanci, Jun Qin, John P. Lydon, Francesco J. DeMayo, all of BCM.

Explore further: Gene mutation discovery sparks hope for effective endometriosis screening

More information: DOI: 10.1038/nm.2826

Related Stories

Gene mutation discovery sparks hope for effective endometriosis screening

February 6, 2012
Researchers at Yale School of Medicine have, for the first time, described the genetic basis of endometriosis, a condition affecting millions of women that is marked by chronic pelvic pain and infertility. The researchers' ...

Recommended for you

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Drug combination may improve impact of immunotherapy in head and neck cancer

September 21, 2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.